Table 3.
Laboratory tests of ATBL in the hematogenous dissemination group and non - hematogenous dissemination group
| Laboratory tests | Hematogenous Dissemination group (n = 75) | Non-hematogenous Dissemination group (n = 103) | P |
|---|---|---|---|
| CD4+ T cell counts (cells/µL) * | 145 (57– 304) | 269 (196–362.5) | < 0.001 |
| Lymphocyte counts (× 109 cells/L) # | 0.70 (0.42–1.31) | 0.92 (0.78–1.24) | 0.003 |
| Tuberculin skin test (positive) & | 37 (37/72, 51.4%) | 66 (66/100 66%) | 0.054 |
| Smear microscopy test for AFB (positive)$ | 28 (28/72, 38.9%) | 13 (13/97, 13.4%) | < 0.001 |
ATBL, abdominal tuberculous lymphadenopathy; AFB, acid-fast bacilli; *, 55 patients were no data; #, 6 patients were no data; &, 6 patients were no data; $, 9 patients were no data